Skip to content
★ Sign in to follow
SK

Surendra K. Ajjarapu

Executive
Chairman & CEO
Scienture Holdings, Inc.Wellgistics Health, Inc.Ocean Biomedical, Inc.Tevogen Inc.Aemetis, Inc
Total declarations
27
Companies
5
▲ Purchases (2 ops.)
€25k
▼ Sales (1 ops.)
—

Latest filing published 25 Jun 2026 for Wellgistics Health, Inc..

Filing timeline

BuySale
Surendra K. Ajjarapu

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Surendra K. Ajjarapu: trading record in brief

Surendra K. Ajjarapu, listed as chief executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Scienture Holdings, Inc., Ocean Biomedical, Inc. and Wellgistics Health, Inc. The record holds 27 filings, for trades running from 9 January 2008 to 22 June 2026.

The open-market side counts 2 purchases for €25k alongside 1 sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 13 share grants.

The newest entry dates from 25 June 2026: a share grant, in Wellgistics Health, Inc. The clock since the last published purchase (23 May 2022) now reads 1,630 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Surendra K. Ajjarapu

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations26 total

25 of 26 declarations